American Biomanufacturing Summit 2025

FUJIFILM Diosynth Biotechnologies is delighted to be attending the American Biomanufacturing Summit, April 15-16, 2025 in San Francisco, CA. Stop by our booth #54 to meet with our team to learn more about our capabilities and how we can be your Partner for Life.

In addition, join our VP of Process Science, Mahalia Corrales, for her presentation on April 16, 9:15-9:45 PST in Room 4:

Leaning into kojoX™ Vision by Building a Flexible Supply Chain Fueled by Innovation 

FUJIFILM Diosynth Biotechnologies’ commitment to industry transformation is at the heart of a multibillion-dollar capital investment in global cell culture capacity expansions.  This capacity expansion will further enable seamless clinical to commercial scale-up and scale-out capability, which is the Company’s kojoX strategy.

The kojoX strategy relies on a uniform operating philosophy across the network of sites with facilities that are highly modularized, standardized, and built for flexibility and speed.  With the kojoX strategy in place, we intend to change the regulatory landscape by affording our partners with supply chain agility across our functionally equivalent network of manufacturing facilities.